Back
Day Range
$14.00
$14.00
52-Week Range
$0.78
$25.00
Volume
5,403,471
50D / 200D Avg
$12.84
/
$6.40
Prev Close
$14.00
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -7.4 | 0.4 |
| P/B | 4.0 | 2.9 |
| ROE % | -54.3 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Debt/Equity of 0.04 — conservative balance sheet
Negative free cash flow of -131.11M
PEG of 0.03 suggests growth is underpriced
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-54.27%
ROIC-42.04%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.04
Current Ratio17.97
Interest Coverage0.00
Valuation
P/E Ratio
-7.43
P/B Ratio3.95
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -135.12M |
| ROE | -54.27% | ROA | -48.86% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -131.11M |
| ROIC | -42.04% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.04 | Current Ratio | 17.97 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -7.43 | P/B Ratio | 3.95 |
| P/S Ratio | N/A | PEG Ratio | 0.03 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.00B | Enterprise Value | 988.04M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -135.12M | -192.96M | -108.43M | -83.75M | -28.17M |
| EPS (Diluted) | -1.97 | -3.30 | -2.06 | -1.69 | -0.56 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -148.45M | -207.99M | -113.14M | -67.15M | -7.05M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 276.56M | 277.69M | 371.40M | 291.48M | 245,000.0 |
| Total Liabilities | 22.52M | 33.77M | 17.51M | 12.28M | 30.90M |
| Shareholders' Equity | 254.05M | 243.92M | 353.90M | 279.20M | -30.65M |
| Total Debt | 10.79M | 12.51M | 1.56M | 0.0 | 12.65M |
| Cash & Equivalents | 27.26M | 51.58M | 64.82M | 70.79M | 244,000.0 |
| Current Assets | 229.63M | 264.35M | 330.69M | 263.02M | 245,000.0 |
| Current Liabilities | 12.78M | 22.27M | 16.36M | 12.28M | 1.40M |